Answers are grounded in this paper and cite their sources.
, and increase the production of short-chain fatty acids (SCFAs). These changes could be related to improved cognitive function, mood regulation, and neuroprotection. However, limitations of these studies (short duration of studies, the variability in VOO composition and the lack of standardized methodologies) need to be overcome. Furthermore, the limited number of human trials and incomplete understanding of the gut-brain axis make it difficult to establish causality and clinical application of the findings. For this reason, future research should focus on long-term clinical trials with larger cohorts, standardised characterisation of VOO and on exploring the synergistic effects with other dietary components. Furthermore, mechanistic studies should aim to uncover the molecular pathways involved in the gut-brain axis to develop specific dietary interventions for neurological and neurodegenerative disorders.
No takes yet. Share an insight, caveat, or question.
Barrera‐Chamorro et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: